- Home
- ZJYL vs GNTA Comparison
ZJYL vs GNTA Comparison
Compare ZJYL & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZJYL | GNTA |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | China | Italy |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 39.4M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZJYL | GNTA |
|---|---|---|
| Price | $0.24 | $1.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 332.8K | 111.6K |
| Earning Date | 08-20-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $22,826,624.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.76 | ★ N/A |
| Revenue Growth | ★ 13.42 | N/A |
| 52 Week Low | $0.22 | $1.35 |
| 52 Week High | $1.42 | $10.00 |
Technical Indicators
Market Signals| Indicator | ZJYL | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.58 | 40.49 |
| Support Level | $0.23 | $1.80 |
| Resistance Level | $0.28 | $2.20 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 13.81 | 59.77 |
Price Performance
Historical ComparisonAbout ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.